Janus Henderson Group
DNA icon

Janus Henderson Group’s Ginkgo Bioworks DNA Stock Holding History

Janus Henderson Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$88.9K Hold
14,534
– – ﹤0.01% 2398
2025
Q4 		$120K Hold
14,534
– – ﹤0.01% 2388
2025
Q3 		$212K Hold
14,534
– – ﹤0.01% 2324
2025
Q2 		$164K Hold
14,534
– – ﹤0.01% 2354
2025
Q1 		$88.9K Hold
14,534
– – ﹤0.01% 2467
2024
Q4 		$143K Buy
14,534
+1
+0% +$9 ﹤0.01% 2488
2024
Q3 		$118K Sell
14,533
-2
-0% -$20 ﹤0.01% 2501
2024
Q2 		$193K Sell
14,535
-170
-1% -$5.07K ﹤0.01% 2398
2024
Q1 		$685K Buy
14,705
+7
+0% +$362 ﹤0.01% 1848
2023
Q4 		$991K Sell
14,698
-23
-0.2% -$1.41K ﹤0.01% 1629
2023
Q3 		$1.07M Buy
14,721
+5,109
+53% +$408K ﹤0.01% 1526
2023
Q2 		$713K Sell
9,612
-17
-0.2% -$1.01K ﹤0.01% 1786
2023
Q1 		$510K Buy
9,629
+4,973
+107% +$315K ﹤0.01% 2010
2022
Q4 		$316K Sell
4,656
-1,567
-25% -$144K ﹤0.01% 1950
2022
Q3 		$778K Buy
6,223
+3,109
+100% +$371K ﹤0.01% 1757
2022
Q2 		$297K Buy
+3,114
New +$380K ﹤0.01% 2084

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group's DNA Position: Q1 2026 in Review

Janus Henderson Group held its Ginkgo Bioworks (DNA) position steady in Q1 2026 at 14,534 shares worth $88.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2398.

Janus Henderson Group first reported a position in DNA in Q2 2022 and has held it in 16 quarters since. The position peaked at $1.07M in Q3 2023. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Janus Henderson Group held 14,534 shares of Ginkgo Bioworks worth $88.9K as of Q1 2026.
  • Janus Henderson Group left its Ginkgo Bioworks share count unchanged in Q1 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2398 holding.
  • Janus Henderson Group first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 16 quarters since.
  • Janus Henderson Group's Ginkgo Bioworks position peaked at $1.07M in Q3 2023.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.